Texas Heart Institute Home
Continuing Medical Education
 
 
 
 
 
 
Browse CME
 
 

 
 
| Share
 
Explore CME by Type
Anticoagulation
15th Annual Health Services Outcomes Research Conference
AMA PRA Category 1
6.75 hrs.
Vascular Injury: The Interface Between Inflammation and Coagulation
AMA PRA Category 1
0.75 hrs.
Selected Problems with Anticoagulation
AMA PRA Category 1
0.75 hrs.
Arrhythmias/Devices
Arrhythmogenic Right Ventricular Dysplasia: What Have We Learned?
AMA PRA Category 1
0.75 hrs.
Ablation of Ventricular Tachycardia in Structural Heart Disease
AMA PRA Category 1
0.75 hrs.
Atrial Fibrillation: Controversy and Consensus
AMA PRA Category 1
0.50 hrs.
The Future of Cardiac Pacing
AMA PRA Category 1
0.75 hrs.
Top 10 Unresolved Questions in ICD Therapy
AMA PRA Category 1
0.75 hrs.
Update in Atrial Fibrillation
AMA PRA Category 1
0.75 hrs.
Wide QRS Tachycardias
AMA PRA Category 1
0.50 hrs.
Cardiovascular Surgery
Molecular Targets in Thoracic Aortic Disease
AMA PRA Category 1
0.75 hrs.
Endovascular Repair of AAA: Current Status and Future Directions
AMA PRA Category 1
0.75 hrs.
Congenital Heart Disease
Interventions in Adult Congenital Heart Disease
AMA PRA Category 1
0.50 hrs.
Echocardiography
6th Annual Houston Echo Review: Boot Camp for 2015 Echo Board
AMA PRA Category 1
16.50 hrs.
Echocardiography: Adult Congenital Heart Disease
AMA PRA Category 1
0.75 hrs.
Echocardiography: Diseases of the Aorta
AMA PRA Category 1
0.50 hrs.
Stress Echo for Evaluation of Patients with Coronary Artery Disease
AMA PRA Category 1
0.75 hrs.
Echo: Prosthetic Valve Dysfunction
AMA PRA Category 1
0.75 hrs.
Echo:Tricuspid and Pulmonary Valve Disease
AMA PRA Category 1
0.75 hrs.
Echo: Aortic Regurgitation
AMA PRA Category 1
0.75 hrs.
Contemporary Echo-Doppler Assessment of LV Systolic Function
AMA PRA Category 1
0.75 hrs.
Ethics
Ethics: Copyright, Plagiarism, and the Internet
AMA PRA Category 1
1.00 hrs.
Surgeons as Mirrors of American Life: A Novel Inquiry in the Ethics of Surgery
AMA PRA Category 1
0.50 hrs.
How to Negotiate the Conversation No Clinician Wants to Have: Discussing Dying from Heart Disease
AMA PRA Category 1
1.00 hrs.
General Cardiology
Coronary Physiology in the Cardiac Catheterization Lab
AMA PRA Category 1
1.00 hrs.
Recreational Drugs and Your Heart
AMA PRA Category 1
0.75 hrs.
Left Ventricular Noncompaction: The Other Cardiomyopathy
AMA PRA Category 1
1.00 hrs.
Yin Yang of Immune Mechanisms in Atherosclerosis
AMA PRA Category 1
1.00 hrs.
Amyloidosis and the Heart
AMA PRA Category 1
1.00 hrs.
STEMI: Adjunct Therapy and Utility of DES
AMA PRA Category 1
0.75 hrs.
Tako-tsubo or Ampulla, Transient Apical Ballooning
AMA PRA Category 1
0.50 hrs.
Heart Failure
Vagus Nerve Stimulation for the Treatment of Heart Failure: Exploring the Heart-Brain Corridor
AMA PRA Category 1
0.75 hrs.
Cardiac BioInterventions: Gene Therapy and Cellular Reprogramming-Has the Day Finally Come?
AMA PRA Category 1
0.75 hrs.
Cardiac Remodeling in Heart Failure
AMA PRA Category 1
0.50 hrs.
The Quality of Care in Heart Failure: Are We Making Progress?
AMA PRA Category 1
0.50 hrs.
Palliative Care in Heart Failure
AMA PRA Category 1
0.75 hrs.
Why Use ACE Inhibitors or ARBs for Heart Failure?
AMA PRA Category 1
0.50 hrs.
The Role of Aldosterone Blockade in Heart Failure
AMA PRA Category 1
1.00 hrs.
History
The History of Cardiology
Texas Heart Institute: An Historic Overview
Imaging
Asymptomatic ECG Abnormalities: What, Me Worry?
AMA PRA Category 1
0.75 hrs.
Imaging and Therapeutics for Atherosclerosis and Angiogenesis
AMA PRA Category 1
0.75 hrs.
Transcranial Doppler Ultrasound: Technique and Application
AMA PRA Category 1
0.75 hrs.
Interventional Cardiology
Percutaneous Aortic Valve Replacement, Patient Selection, Immediate and Long-Term Results
AMA PRA Category 1
0.75 hrs.
Complex Coronary Intervention in the DES Era
AMA PRA Category 1
0.75 hrs.
Latest Findings on Drug-Eluting Stents and CABG Surgery in New York
AMA PRA Category 1
0.50 hrs.
More Topics
Highly Sensitive Troponin Assays
AMA PRA Category 1
0.75 hrs.
Cardiac Disability under Social Security
AMA PRA Category 1
0.50 hrs.
Convergence of Genetics and Stem Cell Biology in Heart Disease
AMA PRA Category 1
0.75 hrs.
Cooley Lecture - Creativity in Surgery by Tirone David, MD
Cardiovascular Specialty of the Next Decade: Bridging Cardiology and Oncology, New Specialty Arises
AMA PRA Category 1
0.75 hrs.
Sleep Apnea and the Importance of Patient Screening
AMA PRA Category 1
0.50 hrs.
Cooley Lecture - Surgical Knife by John Ochsner, MD
Personalized Medicine: An Idea Whose Time is Approaching
AMA PRA Category 1
0.75 hrs.
Cardiovascular Actions of Vitamin D: What Can We Learn from Dialysis Study?
AMA PRA Category 1
0.50 hrs.
PAR-1 and Next-Generation Antiplatelet Therapy in Cardiovascular Medicine
AMA PRA Category 1
0.75 hrs.
Intravascular Ultrasound: Insights into Atherosclerosis
AMA PRA Category 1
0.75 hrs.
Replacement of the Human Heart: Personal Experience
Nanotechnology: Impact on Cardiovascular Medicine
AMA PRA Category 1
0.75 hrs.
Stem Cells in Cardiovascular Disease 2008
Long-Term Use of Antiplatelet Therapy
AMA PRA Category 1
1.00 hrs.
Pathological Cardiac Remodeling: Mechanisms and Therapies
AMA PRA Category 1
0.75 hrs.
Recent Symposia
9th Annual Diabetes Symposium: Diabetes for Primary Care in 2013
AMA PRA Category 1
3.00 hrs.
9th Current Trends in Aortic and Cardiothoracic Surgery and Interventions
AMA PRA Category 1
1.25 hrs.
Risk, Diagnosis and Treatment of Cardiovascular Disease in Women
AMA PRA Category 1
3.25 hrs.
9th Texas Update in Cardiovascular Advancements
AMA PRA Category 1
3.50 hrs.
Denton A. Cooley Cardiovascular Surgical Society 16th International Symposium
AMA PRA Category 1
3.00 hrs.
Heart Failure: Surgical and Medical Breakthrough in Current Practice
AMA PRA Category 1
2.25 hrs.
Tenth Symposium on Cardiac Arrhythmias
AMA PRA Category 1
2.00 hrs.
Emerging Trends in the Management of Arrhythmias and Pump Failure in Patients with Advanced HF
AMA PRA Category 1
4.00 hrs.
Future Direction of Stem Cells in Cardiovascular Disease
AMA PRA Category 1
1.25 hrs.
Percutaneous Closure of PFO and ASD
AMA PRA Category 1
1.00 hrs.
Adult Congenital Heart Disease Symposium
AMA PRA Category 1
3.00 hrs.
Sudden Cardiac Death
Prevention of Sudden Death in the Young: Preliminary Results of Initial 1,836 Cases/MRI Based Study
AMA PRA Category 1
0.75 hrs.
Sudden Cardiac Death in Athletes
AMA PRA Category 1
0.50 hrs.
Sudden Death in Young Athletes
AMA PRA Category 1
0.50 hrs.
 
 
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.


U.S. NEWS America's Best Hospitals 2012-13